Relationship Between BK Viremia, De Novo Anti-HLA DSA, and Outcomes in Renal Transplant Recipients

被引：0
|
作者：
Dieplinger, G. [1 ]
Everly, M. [1 ]
Rebellato, L. [2 ]
Haisch, C. [2 ]
Briley, K. [2 ]
Bolin, P. [2 ]
Kendrick, W. [3 ]
Kendrick, S. [3 ]
Morgan, C. [2 ]
Hoermann, M. [1 ]
Maldonado, A. [4 ]
Harland, R. [2 ]
Terasaki, P. [1 ]
机构：
[1] Terasaki Fdn, Los Angeles, CA USA
[2] E Carolina Univ, Greenville, NC USA
[3] Eastern Nephrol Associates, Greenville, NC USA
[4] Vidant Med Ctr, Greenville, NC USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-00264
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
728
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [1] Relationship Between BK Viremia, De Novo Anti-HLA DSA, and Outcomes in Renal Transplant Recipients.
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Hoermann, M.
    Maldonado, A.
    Harland, R.
    Terasaki, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 85 - 85
  • [2] Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.
    Patel, S.
    Kuten, S.
    Knight, R.
    Nguyen, D.
    Graviss, E.
    Gaber, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 769 - 769
  • [3] Rising Incidence of De Novo Anti-HLA DSA in African American Renal Transplant Recipients Over a Decade
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Hoermann, M.
    Maldonado, A.
    Harland, R.
    Terasaki, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 467 - 467
  • [4] Rising Incidence of De Novo Anti-HLA DSA in African American Renal Transplant Recipients Over a Decade.
    Dieplinger, G.
    Everly, M.
    Rebellato, L.
    Haisch, C.
    Briley, K.
    Bolin, P.
    Kendrick, W.
    Kendrick, S.
    Morgan, C.
    Hoermann, M.
    Maldonado, A.
    Harland, R.
    Terasaki, P.
    [J]. TRANSPLANTATION, 2014, 98 : 467 - 467
  • [5] De Novo Anti-HLA Sensitization in Pediatric Kidney Transplant Recipients
    Vila-Santandreu, A.
    Camacho, J.
    Vila-Cots, J.
    Ramos, M.
    Gondra, L.
    Martorell, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 672 - 672
  • [6] De Novo Anti-HLA Sensitization in Pediatric Kidney Transplant Recipients
    Vila-Santandreu, A.
    Camacho, J.
    Vila-Cots, J.
    Ramos, M.
    Gondra, L.
    Martorell, J.
    [J]. TRANSPLANTATION, 2014, 98 : 672 - 672
  • [7] Development of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients
    Chen, C. K.
    Manlhiot, C.
    Conway, J.
    Allain-Rooney, T.
    McCrindle, B. W.
    Tinckam, K.
    Dipchand, A. I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S193 - S193
  • [8] Role of rituximab for isolated de novo donor specific anti-HLA antibodies in renal transplant recipients
    Schafer, Antonia
    Ferrai-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    [J]. SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [9] IMPACT OF EVEROLIMUS ON DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 245 - 245
  • [10] When Is the Best Time to Screen for De Novo Donor Specific Anti-HLA Antibodies (DSA) in Low-Risk Renal Transplant Recipients?
    Everly, M.
    Rebellato-deVente, L. M.
    Haisch, C. E.
    Ozawa, M.
    Parker, K.
    Briley, K. P.
    Catrou, P. G.
    Bolin, P.
    Kendrick, W. T.
    Kendrick, S. A.
    Harland, R. C.
    Terasaki, P., I
    [J]. TRANSPLANTATION, 2012, 94 (10) : 1190 - 1190
12345